| Unit name | Cracking Causality |
|---|---|
| Unit code | SSCM30009 |
| Credit points | 10 |
| Level of study | H/6 |
| Teaching block(s) |
Teaching Block 2 (weeks 13 - 24) |
| Unit director | Dr. Zuccolo |
| Open unit status | Not open |
| Pre-requisites |
This is part of an intercalated BSc for Medical, Veterinary or Dental students |
| Co-requisites |
None |
| School/department | Bristol Medical School |
| Faculty | Faculty of Health Sciences |
Using genetic data to discover the environmental causes of disease. Topics include Mendelian randomisation, study design and translation from genetics to new drugs and new policies.
1. Illustrate the issues in observational epidemiological studies.
2. Explain the assumptions of Mendelian randomisation and how genetic variants can be used to improve causal inference.
3. Critique the Mendelian randomisation approach for making causal inference in epidemiology and discuss what can be done to mitigate the limitations of Mendelian randomisation
4. Discuss the main features of successful targets for drug discovery or policy implementation and explain how Mendelian randomisation could inform these.
5. Interpret findings from an Mendelian randomisation study in a clinical setting.
6. Critically appraise the evidence from a published Mendelian randomisation study.
7. Design an Mendelian randomisation study.
Methods of Teaching
This unit will adopt a blended learning approach, including a mixture of interactive synchronous and asynchronous sessions. Where appropriate, this will include some on-campus teaching, but all materials will be available for online learning.
Student Input
10 hours of scheduled activities, 5 hours coursework, a proportion of an end-of-programme assessment, and 75 hours independent study
Assessment Information
50% of the available marks will be allocated through an in-unit coursework, with the remaining 50% allocated through an end-of-programme assessment.
Lewin – Genes XI - 2013
Strachan and Read – Human Molecular Genetics – 4th Edition - 2010
Davey Smith G, Ebrahim S (2004) Mendelian Randomisation: prospects, potentials and limitations. International Jounal of Epidemiology 33: 30-42.
Davey Smith G, Lawlor DA, Harbord R, Timpson N, Day I, Ebrahim S (2007) Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med 4: e352.
Freathy RM, Timpson NJ, Lawlor DA, Pouta A, Ben-Shlomo Y, Ruokonen A, Ebrahim S, Shields B, Zeggini E, Weedon MN, et al. (2008) Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes 57: 1419-1426.
Lawlor DA, Harbord RM, Sterne JAC, Timpson NJ, Davey Smith G (2008) Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Statistics in Medicine 27: 1133-1163.
Davey Smith G (2010) Mendelian randomization for strengthening causal inference in observational studies: application to gene by environment interaction. Perspectives
Davey Smith G (2011) Epidemiology, epigenetics and the ‘Gloomy Prospect’: embracing randomness in
population health research and practice. International Journal of Epidemiology 40: 537-562.
Nordestgaard BG, Palmer TM, Benn M, Zacho J, Tybjaerg-Hansen A, Davey Smith G, Timpson NJ (2012) The Effect of Elevated Body Mass Index on Ischemic Heart Disease Risk: Causal Estimates from a Mendelian Randomisation Approach. PLoS Med 9: e1001212.
Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, Davey Smith G, Sterne JAC (2012) Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res 21: 223-242.
Brion M-JA, Shakhbazov K, Visscher PM (2013) Calculating statistical power in Mendelian randomization studies. International Journal of Epidemiology 42: 1497-1501.
Evans DM, Brion MJA, Paternoster L, Kemp JP, McMahon G, Munafò M, Whitfield JB, Medland SE, Montgomery GW, Timpson NJ, et al. (2013) Mining the Human Phenome Using Allelic Scores That Index Biological Intermediates. PLoS Genetics 9: e1003919.
Fall T, Hägg S, Mägi R, Ploner A, Fischer K, Horikoshi M, Sarin A-P, Thorleifsson G, Ladenvall C, Kals M, et al. (2013) The Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis. PLoS Med 10: e1001474.
Palmer TM, Nordestgaard BG, Benn B, Tybjærg-Hansen A, Davey Smith G, Lawlor DA, Timpson NJ (2013) Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. BMJ 347.
Pierce BL, Burgess S (2013) Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable Estimators. American Journal of Epidemiology 178: 1177-1184.
